Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects

Martin Hill / Dušan Lukáč / Oldrrich Lapčík / Jarmila Šulcová / Richard Hampl / Vladimír Pouzar / Luboslav Stárka

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 37, Issue 4, Pages 439–447, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.1999.072, June 2005

Publication History

Published Online:
2005-06-01

Abstract

17-Hydroxypregnenolone (3β, 17α-dihydroxypregn-5-en-20-one) and pregnenolone (3β-hydroxypregn-5-en-20-one) were determined by radioimmunoassay following HPLC separation in serum of healthy subjects of both sexes from 2 to 66 years old (29 girls, 85 women, 30 boys, 89 men). The effects of age and sex on the levels of both steroids were investigated and the upper limits of normal in age groups were determined.

The 17-hydroxypregnenolone levels as a function of age were characterized by a statistically significant maximum at the age of 18 and 20 years followed by a local minimum at the age of 39 and 37 years and by a statistically insignificant local maximum at the age of 55 and 49 years in men and women, respectively.

Pregnenolone age-dependence was similar and the statistically significant maximum was reached at the age of 17 and 16 years, the local minimum occurred at the age of 37 and 38 years and the second, statistically insignificant, local maximum at the age of 48 and 47 years in men and women, respectively.

Both 17-hydroxypregnenolone and pregnenolone in both sexes exhibited similarly shaped peaks with age. Both peaks of the polynomial fit in 17-hydroxypregnenolone were more pronounced in men than in women (13.0 and 9.20 nmol/l in the first peak; 7.72 and 4.78 in the second peak respectively). The situation with pregnenolone was the opposite. Both peaks of the polynomial fit in pregnenolone were lower in men than in women (2.29 and 3.21 nmol/l in the first peak; 0.92 and 1.78 in the second peak, respectively).

The higher serum levels of pregnenolone at puberty and during fertile age and their wider variance in comparison with men could, be explained by the different gonadal steroidogenesis depending on the menstrual cycle, where the pregnenolone serves as a substrate for progesterone formation.

The age dependencies of 17-hydroxypregnenolone and pregnenolone in women resembled that of unconjugated dehydroepiandrosterone. These results indicate that the increased metabolic activity in gonads in adolescence concerns not only dehydroepiandrosterone as the product of the 5-ene metabolic pathway but also its precursors.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Michael S. Ritsner, Hisham Bawakny, and Anatoly Kreinin
Psychiatry and Clinical Neurosciences, 2014, Volume 68, Number 6, Page 432
[2]
Jinpei Kumagai, Johannes Hofland, Sigrun Erkens-Schulze, Natasja F.J. Dits, Jacobie Steenbergen, Guido Jenster, Yukio Homma, Frank H. de Jong, and Wytske M. van Weerden
The Prostate, 2013, Page n/a
[3]
Robert Morfin
The Journal of Steroid Biochemistry and Molecular Biology, 2002, Volume 80, Number 3, Page 273
[4]
M Hill, A Pařı́zek, J Klak, R Hampl, J Šulcová, H Havlı́ková, O Lapčı́k, M Bičı́ková, T Fait, R Kancheva, D Cibula, V Pouzar, M Meloun, and L Stárka
The Journal of Steroid Biochemistry and Molecular Biology, 2002, Volume 82, Number 2-3, Page 241
[5]
M. Schumacher, S. Weill-Engerer, P. Liere, F. Robert, R.J.M. Franklin, L.M. Garcia-Segura, J.J. Lambert, W. Mayo, R.C. Melcangi, A. Parducz, U. Suter, C. Carelli, E.E. Baulieu, and Y. Akwa
Progress in Neurobiology, 2003, Volume 71, Number 1, Page 3
[6]
A.W. Meikle, M.M. Kushnir, A:L. Rockwood, E.G. Pattison, A.H. Terry, T. Sandrock, A.M. Bunker, A.R. Phanslkar, W.E. Owen, and W.L. Roberts
Journal of Pediatric Endocrinology and Metabolism, 2007, Volume 20, Number 12
[7]
Marie Bičíková, Daniela Řípová, Martin Hill, Roman Jirák, Helena Havlíková, Jaroslava Tallová, and Richard Hampl
Clinical Chemistry and Laboratory Medicine, 2004, Volume 42, Number 5
[8]
Martin Hill, Helena Havlíková, Jan Klak, Marie Bičíková, Vladimír Pouzar, Richard Hampl, and Luboslav Stárka
Collection of Czechoslovak Chemical Communications, 2002, Volume 67, Number 1, Page 140

Comments (0)

Please log in or register to comment.